By using this model, we proposed that (i) LCH is a Mo-DC-related disease rather than an LC-related disease, (ii) IL-17A is a source of inflammation in LCH lesions and (iii) LCH-DCs acquire the ability to survive and thus to accumulate. This evidence concerns the gene IL17A and Langerhans cell histiocytosis.